ZIMV News and Press, ZimVie Inc. From 03/02/23

The shares of the MedTech company ZimVie ( NASDAQ: ZIMV ) lost ~37% in the morning hours Thursday to reach the lowest level since its 2022 IPO after reporting lower-than-expected Q4 2022 financials and setting its guidance below the consensus. ZimVie ( ZIMV ), which IPO’...

Gainers: OncoSec Medical ( ONCS ) +44% . BioRestorative Therapies BRTX +32% . Astria Therapeutics ( ATXS ) +13% . Certara ( CERT ) +12% . Kazia Therapeutics ( KZIA ) +11% . Losers: ZimVie ( ZIMV ) -45% . Cano Health ( CAN...

Silvergate Capital SI -43% after crypto bank delays SEC filing; J.P. Morgan turns bearish . Funko FNKO -26% on Q4 earnings release . ZimVie ZIMV -23% on Q4 earnings release . Cano Health CANO -20% on Q4 earnings release . Aehr Test ( AEHR ) -2...

Image source: The Motley Fool. ZimVie (NASDAQ: ZIMV) Q4 2022 Earnings Call Mar 01, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: ZimVie (ZIMV) Q4 2022 Earnings Call Transcript

ZimVie Inc. (ZIMV) Q4 2022 Earnings Conference Call March 01, 2023 04:30 PM ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President & Chief Executive Officer Rich Heppenstall - Chief Financial Officer Conference Call Participants ...

ZimVie press release ( NASDAQ: ZIMV ): Q4 Non-GAAP EPS of $0.16 misses by $0.05 . Revenue of $229.12M (-12.4% Y/Y) misses by $7.88M . FY23 expected revenue of $825M - $850M, vs. consensus of $924.63M. Non-GAAP EPS of $0.30 - $0.50, vs. consensus of $1.29....

FY 2022 Third Party Net Sales of $909.5 million FY 2022 Net Loss of ($63.9) million; Net Loss Margin of (7.0%); Adjusted Net Income [ 1] of $47.9 million FY 2022 Diluted EPS of ($2.45); Adjusted Diluted EPS [ 1] of $1.84 FY 2022 Adju...

WESTMINSTER, Colo., Feb. 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the RealGUIDE™ CAD and FULL SUITE modules, the latest innovations within ZimVie’s digital dentistry software...

WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full year 2022 after market close on Wednesday, March 1, 2023. Management will hos...

WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs have been implanted worldwide. This includes patients treated in over 25 countries since the fir...